Product Description
Potential Uses
How PolyHeme® Is Made
Clinical Trial Experience
Non-Randomized
Trauma Trial
PolyHeme® Pivotal
Phase III Trial
Potential Battlefield Use
Development History
Selected Bibliography

 

Potential Battlefield Use

The Department of Defense and all branches of the military have had a long-standing interest in the successful development of a hemoglobin-based oxygen carrier (HBOC) to serve as a red blood cell substitute. The ideal properties of an HBOC for military use include:

  • Universal compatibility
  • Long-term storage capability
  • Reduction of disease transmission
  • Safety during rapid, massive infusion
  • The ability to support life in humans in the virtual absence of any of the patient’s own red blood cells

Northfield’s collaboration with the U.S. Army dates back to 1969. We are currently exploring the potential use of PolyHeme® in patients in shock in remote battlefield settings, where red blood cells are not available. In such circumstances, PolyHeme® has the potential to simplify and facilitate the early treatment of such urgent blood loss by permitting immediate, rapid, and simultaneous replacement of the lost volume and hemoglobin that occurs with hemorrhage.

©2006 Northfield Laboratories Inc. · Safe Harbor · Terms of Use · Privacy Policy